Caveolin-1: a complex and provocative therapeutic target in prostate cancer and potentially other malignancies
- 1 June 1999
- journal article
- Published by Informa Healthcare in Emerging Therapeutic Targets
- Vol. 3 (2), 337-346
- https://doi.org/10.1517/14728222.3.2.337
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Molecular Genetics of the Caveolin Gene Family: Implications for Human Cancers, Diabetes, Alzheimer Disease, and Muscular DystrophyAmerican Journal of Human Genetics, 1998
- Caveolae, DIGs, and the dynamics of sphingolipid—cholesterol microdomainsCurrent Opinion in Cell Biology, 1997
- Functional rafts in cell membranesNature, 1997
- Identification, Sequence, and Expression of an Invertebrate Caveolin Gene Family from the Nematode Caenorhabditis elegansJournal of Biological Chemistry, 1997
- Caveolae and caveolinsCurrent Opinion in Cell Biology, 1996
- De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.Proceedings of the National Academy of Sciences, 1995
- Cytotoxic chemotherapy for advanced hormone-resistant prostate cancerCancer, 1993
- Caveolin, a protein component of caveolae membrane coatsCell, 1992
- Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organCell, 1989